Targeted Epigenetic Modification to Improve Mesothelioma Responses to Immunotherapy

Project Details

StatusFinished
Effective start/end date30/09/2029/09/22

Funding

  • US Department of Defense: A$76,934.00
  • US Department of Defense: A$181,591.00
  • US Department of Defense: A$287,099.00